CH3100 - Molecular Basis of Therapeutics 4
| Credit points: | 03 |
| Year: | 2017 |
| Student Contribution Band: | Band 2 |
| Administered by: | College of Science and Engineering |
Available to students who are enrolled in the BPharm, BPharm IHCAP Program and the BPharm Honours Programs.
This subject will examine the medicinal chemistry relevant to the process of drug discovery and development as practised in the modern pharmaceutical industry. Building on the material covered in Pc2001 and Pc2002, it will develop in students a knowledge of the research tools which are applied to this process including high throughput screening, computational chemistry and molecular modelling, QSAR, combinatorial synthesis techniques and the application of genomics. The specific application of these tools to drug classes of clinical significance will be illustrated by a case-study approach.Assessment by a three-hour examination (70%); drug profile assignment, participation in workshops (30%).
Learning Outcomes
- an appreciation of the interdisciplinary nature of the drug discovery and development process;
- experience of the application of these tools to specific drug classes of clinical significance;
- knowledge of the range of research tools available for this process.
| Prerequisites: | BC2014 and PC2002 and PC2004 and PC2006 and HS2401 and PC2001 and PC2003 and PC2201. |
Availabilities | |
| Townsville, Internal, Study Period 2 | |
| Census Date 24-Aug-2017 | |
| Coordinator: | Assoc. Professor Michael Oelgemoeller |
| Lecturers: | Professor Beverley Glass, Assoc. Professor Michael Oelgemoeller, Assoc. Professor Bruce Bowden, mobjm. |
| Contact hours: |
|
| Assessment: | end of semester exam (70%); assignments (30%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.